Next-generation sequencing (NGS), alternatively known as high-throughput sequencing, allows sequencing of millions of DNA molecules simultaneously. This method is useful in the field of personalized medicine, genetic diseases and clinical diagnostics as it offers high throughput option with ability to perform sequencing for multiple individual at the same time. The NGS machine or NGS sequencer is flexible enough to operate tasks such as whole –genome sequencing (WGS), targeted sequencing and transcriptome analysis. The Global Next-Generation Sequencing market is expected to grow at a CAGR of 18.64% from (2019-2024) and market size is projected to reach at USD 15.87 Billion by 2024.
This growth is primarily driven by Technical Advancement in NGS platform and Ability to Provide Cost Effective Solution.
Globally, a noticeable market trend is evident Development in Portable Sequencing Technology
. The Health Care sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as 10x Genomics (United States), Agilent Technologies, Inc. (United States), Beckman Coulter (A Subsidiary of Danaher), Becton, Dickinson and Company (United States), BGI (China), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche AG (Switzerland), Genewiz (United States), Illumina, Inc. (United States), Macrogen, Inc. (South Korea) and Oxford Nanopore Technologies, Ltd. (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Recently in March 2018, ARUP and metagenomics company IDbyDNA, Inc. launched Explify Respiratory which is an NGS test for respiratory infections that helps physicians while diagnosing patients with pneumonia and other respiratory diseases. Using nucleic acid the test identifies over 200 common and rare bacteria and viruses.
In April 2018, Food and Drug Administration (FDA) finalized a guidance document, Considerations for Design, Development, and Analytical Validation of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Intended to Aid in the Diagnosis of Suspected Germline Diseases, in efforts to accelerate the establishment of a regulatory approach for next generation sequencing (NGS) testing. FDA has provided a step toward integrating NGS into clinical practice, the document has rekindled the debate about t
- Technical Advancement in NGS platform
- Ability to Provide Cost Effective Solution
- Development in Portable Sequencing Technology
- Adoption and Integration of Advanced LIMS (Laboratory Information Management System) Real-Time Tracking Method
- Lack of Budget in Emerging Economies
- Lack of Awareness About NGS Technology
Favorable Government Initiatives and Incorporation of Big Data
Issue Related to Ethics and Problem Associated With Interpretation of Complex Data
AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Next-Generation Sequencing Study Sheds Light on
The Next-Generation Sequencing Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Next-Generation Sequencing industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Next-Generation Sequencing industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.